Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop · Investor's Business Daily
ALLISON GATLIN
2 min read

In This Article:

Guardant Health stock jumped Thursday on an "impressive" third-quarter report following the launch of its cancer detection test, Shield.

Recommended Stories